PT Wickland Medika Imantara is proud to announce that BONGOLD Biomimetic Mineralized Bone Graft Material has been successfully used in bone fusion procedures by spine surgeons. Designed to mimic the natural structure of bone, BONGOLD supports bone regeneration and promotes faster healing. In several clinical cases in China, the product has been applied in spinal fusion, interbody fusion, and other bone reconstruction procedures. Early results demonstrate excellent integration with the patient’s native bone, confirming BONGOLD as a safe and effective solution for modern bone fusion procedures.

BONGOLD’s osteoconductive properties facilitate optimal new bone growth at the fusion site, while its structural stability helps maintain the required fusion space. The material also demonstrates excellent biocompatibility, supporting the body’s natural healing process and providing confidence to surgeons during application.

The successful clinical use of BONGOLD reinforces the company’s commitment to delivering high-quality biomaterial solutions. The company will continue to collaborate with medical professionals and drive innovation to support improved clinical outcomes and enhance patients’ quality of life through safe and reliable technology.